APA (7th ed.) Citation

E, T., A, G., A, N., F, P., T, B., FM, R., . . . V, G. (2024). The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: A novel anchor-independent mechanism exploiting soluble blood-borne ligands. Leukemia, 38(10), 2127. https://doi.org/10.1038/s41375-024-02376-7

Chicago Style (17th ed.) Citation

E, Tissino, et al. "The VLA-4 Integrin Is Constitutively Active in Circulating Chronic Lymphocytic Leukemia Cells via BCR Autonomous Signaling: A Novel Anchor-independent Mechanism Exploiting Soluble Blood-borne Ligands." Leukemia 38, no. 10 (2024): 2127. https://doi.org/10.1038/s41375-024-02376-7.

MLA (9th ed.) Citation

E, Tissino, et al. "The VLA-4 Integrin Is Constitutively Active in Circulating Chronic Lymphocytic Leukemia Cells via BCR Autonomous Signaling: A Novel Anchor-independent Mechanism Exploiting Soluble Blood-borne Ligands." Leukemia, vol. 38, no. 10, 2024, p. 2127, https://doi.org/10.1038/s41375-024-02376-7.